C6461001 An Interventional Phase 3, Double-blind, Randomized Study to Evaluate Efficacy and Safety of PF-08634404 in Combination with Chemotherapy Versus Pembrolizumab in Combination with Chemotherapy in Adult Participants with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Phase III
  • Trial Category: Lung

Contact(s)

Mary Beth Wilwerding, RN   Admin@NEcancertrials.com

Location(s)

Available at Cancer Partners of Nebraska, Lincoln, NE location, and available at Nebraska Hematology and Oncology, Lincoln, NE location

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*